For citations:

Sabirov I.S., Murkamilov I.T., Fomin V.V. Potential mechanisms underlying cardiovascular protection by sodium glucose cotransporter 2 inhibitors (empagliflozin). Complex Issues of Cardiovascular Diseases. 2021;10(3):79-89. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-3-79-89